HEADER SIGNALING PROTEIN 07-MAR-18 6CN5 TITLE HUMAN RETENOID-RELATED ORPHAN RECEPTOR-GAMMA LIGAND- BINDING DOMAIN IN TITLE 2 COMPLEX WITH INDOLE LIGAND CP9B IN INVERSE AGONIST CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ROR GAMMA, LIGAND-BINDING, NUCLEAR RECEPTOR, NON STEROIDAL, INDOLE, KEYWDS 2 PFIZER, INVERSE AGONIST, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.KAUPPI,F.VAJDOS REVDAT 4 04-OCT-23 6CN5 1 REMARK REVDAT 3 01-MAY-19 6CN5 1 JRNL REVDAT 2 19-SEP-18 6CN5 1 JRNL REVDAT 1 05-SEP-18 6CN5 0 JRNL AUTH M.E.SCHNUTE,M.WENNERSTAL,J.ALLEY,M.BENGTSSON,J.R.BLINN, JRNL AUTH 2 C.W.BOLTEN,T.BRADEN,T.BONN,B.CARLSSON,N.CASPERS,M.CHEN, JRNL AUTH 3 C.CHOI,L.P.COLLIS,K.CROUSE,M.FARNEGARDH,K.F.FENNELL,S.FISH, JRNL AUTH 4 A.C.FLICK,A.GOOS-NILSSON,H.GULLBERG,P.K.HARRIS,S.E.HEASLEY, JRNL AUTH 5 M.HEGEN,A.E.HROMOCKYJ,X.HU,B.HUSMAN,T.JANOSIK,P.JONES, JRNL AUTH 6 N.KAILA,E.KALLIN,B.KAUPPI,J.R.KIEFER,J.KNAFELS,K.KOEHLER, JRNL AUTH 7 L.KRUGER,R.G.KURUMBAIL,R.E.KYNE JR.,W.LI,J.LOFSTEDT, JRNL AUTH 8 S.A.LONG,C.A.MENARD,S.MENTE,D.MESSING,M.J.MEYERS, JRNL AUTH 9 L.NAPIERATA,D.NOTEBERG,P.NUHANT,M.J.PELC,M.J.PRINSEN, JRNL AUTH10 P.RHONNSTAD,E.BACKSTROM-RYDIN,J.SANDBERG,M.SANDSTROM,F.SHAH, JRNL AUTH11 M.SJOBERG,A.SUNDELL,A.P.TAYLOR,A.THORARENSEN,J.I.TRUJILLO, JRNL AUTH12 J.D.TRZUPEK,R.UNWALLA,F.F.VAJDOS,R.A.WEINBERG,D.C.WOOD, JRNL AUTH13 L.XING,E.ZAMARATSKI,C.W.ZAPF,Y.ZHAO,A.WILHELMSSON,G.BERSTEIN JRNL TITL DISCOVERY OF 3-CYANO- JRNL TITL 2 N-(3-(1-ISOBUTYRYLPIPERIDIN-4-YL) JRNL TITL 3 -1-METHYL-4-(TRIFLUOROMETHYL)-1 H-PYRROLO[2,3- JRNL TITL 4 B]PYRIDIN-5-YL)BENZAMIDE: A POTENT, SELECTIVE, AND ORALLY JRNL TITL 5 BIOAVAILABLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR JRNL TITL 6 C2 INVERSE AGONIST. JRNL REF J. MED. CHEM. V. 61 10415 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30130103 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00392 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 82.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 29699 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1575 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2169 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1720 REMARK 3 BIN FREE R VALUE SET COUNT : 123 REMARK 3 BIN FREE R VALUE : 0.2550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3776 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.04000 REMARK 3 B22 (A**2) : 1.04000 REMARK 3 B33 (A**2) : -1.56000 REMARK 3 B12 (A**2) : 0.52000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.214 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.190 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.128 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.960 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 RESIDUES AFTER 495 ARE DISORDERED REMARK 4 REMARK 4 6CN5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1000233041. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31330 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 135.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.33 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.23 REMARK 200 R MERGE FOR SHELL (I) : 0.54000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.430 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 1B0W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8-2.5M NA FORMATE, 0.1 MTRIS-HCL PH REMARK 280 7.5-8.0, 3% METHYL PENTANE DIOL, VAPOR DIFFUSION, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.29900 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.59800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 67.94850 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 113.24750 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 22.64950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 257 REMARK 465 PRO A 258 REMARK 465 THR A 259 REMARK 465 PRO A 260 REMARK 465 GLU A 261 REMARK 465 ALA A 262 REMARK 465 PRO A 263 REMARK 465 TYR A 264 REMARK 465 ALA A 496 REMARK 465 ALA A 497 REMARK 465 PHE A 498 REMARK 465 PRO A 499 REMARK 465 PRO A 500 REMARK 465 LEU A 501 REMARK 465 TYR A 502 REMARK 465 LYS A 503 REMARK 465 GLU A 504 REMARK 465 LEU A 505 REMARK 465 PHE A 506 REMARK 465 SER A 507 REMARK 465 THR A 508 REMARK 465 GLU A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 SER A 512 REMARK 465 PRO A 513 REMARK 465 VAL A 514 REMARK 465 GLY A 515 REMARK 465 LEU A 516 REMARK 465 SER A 517 REMARK 465 LYS A 518 REMARK 465 GLY B 257 REMARK 465 PRO B 258 REMARK 465 THR B 259 REMARK 465 PRO B 260 REMARK 465 GLU B 261 REMARK 465 ALA B 262 REMARK 465 PRO B 263 REMARK 465 TYR B 264 REMARK 465 ALA B 496 REMARK 465 ALA B 497 REMARK 465 PHE B 498 REMARK 465 PRO B 499 REMARK 465 PRO B 500 REMARK 465 LEU B 501 REMARK 465 TYR B 502 REMARK 465 LYS B 503 REMARK 465 GLU B 504 REMARK 465 LEU B 505 REMARK 465 PHE B 506 REMARK 465 SER B 507 REMARK 465 THR B 508 REMARK 465 GLU B 509 REMARK 465 THR B 510 REMARK 465 GLU B 511 REMARK 465 SER B 512 REMARK 465 PRO B 513 REMARK 465 VAL B 514 REMARK 465 GLY B 515 REMARK 465 LEU B 516 REMARK 465 SER B 517 REMARK 465 LYS B 518 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 278 CB CYS A 278 SG -0.143 REMARK 500 SER A 399 CB SER A 399 OG -0.085 REMARK 500 CYS B 278 CB CYS B 278 SG -0.202 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 310 NE - CZ - NH1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG A 310 NE - CZ - NH2 ANGL. DEV. = -6.9 DEGREES REMARK 500 LEU B 287 CB - CG - CD1 ANGL. DEV. = 13.1 DEGREES REMARK 500 ARG B 288 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG B 310 NE - CZ - NH1 ANGL. DEV. = 5.3 DEGREES REMARK 500 ARG B 310 NE - CZ - NH2 ANGL. DEV. = -5.9 DEGREES REMARK 500 CYS B 393 CA - CB - SG ANGL. DEV. = 7.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -71.18 82.90 REMARK 500 SER A 339 -75.10 -13.41 REMARK 500 GLU A 435 63.13 -108.57 REMARK 500 GLN B 286 -65.71 78.82 REMARK 500 GLU B 435 63.81 -117.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F7M A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F7M B 601 DBREF 6CN5 A 259 518 UNP P51449 RORG_HUMAN 259 518 DBREF 6CN5 B 259 518 UNP P51449 RORG_HUMAN 259 518 SEQADV 6CN5 GLY A 257 UNP P51449 EXPRESSION TAG SEQADV 6CN5 PRO A 258 UNP P51449 EXPRESSION TAG SEQADV 6CN5 GLY B 257 UNP P51449 EXPRESSION TAG SEQADV 6CN5 PRO B 258 UNP P51449 EXPRESSION TAG SEQRES 1 A 262 GLY PRO THR PRO GLU ALA PRO TYR ALA SER LEU THR GLU SEQRES 2 A 262 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 3 A 262 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 4 A 262 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 5 A 262 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 6 A 262 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 7 A 262 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 8 A 262 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 9 A 262 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 10 A 262 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 11 A 262 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 12 A 262 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 13 A 262 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 14 A 262 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 15 A 262 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 16 A 262 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 17 A 262 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 18 A 262 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 19 A 262 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 20 A 262 GLU LEU PHE SER THR GLU THR GLU SER PRO VAL GLY LEU SEQRES 21 A 262 SER LYS SEQRES 1 B 262 GLY PRO THR PRO GLU ALA PRO TYR ALA SER LEU THR GLU SEQRES 2 B 262 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 3 B 262 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 4 B 262 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 5 B 262 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 6 B 262 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 7 B 262 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 8 B 262 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 9 B 262 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 10 B 262 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 11 B 262 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 12 B 262 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 13 B 262 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 14 B 262 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 15 B 262 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 16 B 262 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 17 B 262 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 18 B 262 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 19 B 262 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 20 B 262 GLU LEU PHE SER THR GLU THR GLU SER PRO VAL GLY LEU SEQRES 21 B 262 SER LYS HET F7M A 601 35 HET F7M B 601 35 HETNAM F7M 4-CYANO-N-{3-[1-(CYCLOHEXANECARBONYL)PIPERIDIN-4-YL]-1- HETNAM 2 F7M METHYL-1H-INDOL-5-YL}PYRIDINE-2-CARBOXAMIDE FORMUL 3 F7M 2(C28 H31 N5 O2) FORMUL 5 HOH *100(H2 O) HELIX 1 AA1 SER A 266 THR A 284 1 19 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 LYS A 311 1 11 HELIX 5 AA5 SER A 312 LEU A 338 1 27 HELIX 6 AA6 LEU A 338 GLU A 343 1 6 HELIX 7 AA7 CYS A 345 MET A 365 1 21 HELIX 8 AA8 GLY A 384 GLY A 392 5 9 HELIX 9 AA9 CYS A 393 ALA A 409 1 17 HELIX 10 AB1 SER A 413 ILE A 426 1 14 HELIX 11 AB2 GLU A 435 THR A 457 1 23 HELIX 12 AB3 ARG A 459 LEU A 466 5 8 HELIX 13 AB4 GLY A 470 HIS A 490 1 21 HELIX 14 AB5 SER B 266 THR B 284 1 19 HELIX 15 AB6 ARG B 288 GLN B 295 1 8 HELIX 16 AB7 ARG B 296 ASN B 298 5 3 HELIX 17 AB8 SER B 301 LYS B 311 1 11 HELIX 18 AB9 SER B 312 LEU B 338 1 27 HELIX 19 AC1 GLY B 340 LEU B 344 5 5 HELIX 20 AC2 CYS B 345 MET B 365 1 21 HELIX 21 AC3 GLU B 386 GLY B 392 5 7 HELIX 22 AC4 CYS B 393 ALA B 409 1 17 HELIX 23 AC5 SER B 413 ILE B 426 1 14 HELIX 24 AC6 GLU B 435 THR B 457 1 23 HELIX 25 AC7 ARG B 459 LEU B 466 5 8 HELIX 26 AC8 PRO B 468 HIS B 490 1 23 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 384 -1 O LYS B 381 N PHE B 378 CISPEP 1 VAL B 493 VAL B 494 0 21.21 CISPEP 2 VAL B 494 GLN B 495 0 23.37 SITE 1 AC1 21 CYS A 285 GLN A 286 LEU A 287 CYS A 320 SITE 2 AC1 21 HIS A 323 LEU A 324 MET A 365 ARG A 367 SITE 3 AC1 21 ALA A 368 VAL A 376 PHE A 377 PHE A 388 SITE 4 AC1 21 CYS A 393 LEU A 396 ILE A 397 ILE A 400 SITE 5 AC1 21 PHE A 401 SER A 404 HIS A 479 ARG A 482 SITE 6 AC1 21 HOH A 726 SITE 1 AC2 20 CYS B 285 GLN B 286 LEU B 287 CYS B 320 SITE 2 AC2 20 HIS B 323 LEU B 324 MET B 365 ARG B 367 SITE 3 AC2 20 ALA B 368 VAL B 376 PHE B 377 PHE B 388 SITE 4 AC2 20 CYS B 393 LEU B 396 ILE B 400 PHE B 401 SITE 5 AC2 20 SER B 404 HIS B 479 HOH B 736 HOH B 740 CRYST1 95.663 95.663 135.897 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010453 0.006035 0.000000 0.00000 SCALE2 0.000000 0.012071 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007359 0.00000